Boards & Committees - Grants & Awards
Grants & Awards Committee COMMITTEE CO-CHAIRS:
Wednesday, April 15, 2015, 12:45 PM - 2:45 PM
Acropolis Congres Centre, Nice, France
- The Grants and Awards Committee shall consist of three Chairs, at least one representing heart and one representing lung and at least one from the US and one from outside the US, appointed by the Board of Directors and serving 3-year staggered terms.
- Grants and awards reviewers shall be appointed by the Co-Chairs for 1-year terms, renewable up to three times.
- The number of grants and awards reviewers shall be determined by the Co-Chairs according to their needs and to reflect the geographic and specialty diversity of the Society members.
- Oversee and administer the Society’s grant and awards program, including the grant application process, the application review and selection process, and the oversight of grant award follow-up reports.
- Manage the process of determining each year’s Caves Award Winner and administer any other awards programs assigned to it by the Board of Directors.
Yale New Haven Hospital
New Haven, CT, USA
firstname.lastname@example.orgAs a physician-scientist and transplant immunologist, Dr. Goldstein examines how the innate immune system, in particular Toll-like receptors, impact alloimmunity and transplant tolerance. His work as a board certified transplant cardiologist affords him insights into whether preclinical immunological studies are relevant to solid organ transplantation. In addition, his research involves studies on how aging impacts innate immunity and the role of aging on alloimmmunity. In particular, his laboratory has discovered new pathways by which aging alters inflammation during acute viral infections, atherosclerosis, and information that age-induced inflammatory responses impact the tempo of acute allograft rejection and transplant tolerance.
Newcastle Upon Tyne, UK
email@example.comAndrew Fisher is Academic Director and Honorary Consultant Respiratory and Transplant Physician at the Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne and Professor of Respiratory Transplant Medicine at Newcastle University Medical School. He graduated from Nottingham University in 1993 and received research training as an Medical Research Council training fellow in Newcastle and Edinburgh 1996-99. He was subsequently awarded a GlaxoSmithKline Senior Clinical Research Fellowship 2005-2010. He has previously served as Chair of the British Thoracic Society Science and Research Committee 2009-2012 and Chair of the European Respiratory Society Lung Transplant Group 2010-2013.RESEARCH FELLOWSHIP GRANT and NORMAN E SHUMWAY CAREER DEVELOPMENT AWARD REVIEWERS:INTERNATIONAL TRAVELING SCHOLARSHIP AWARDS:
Newcastle Upon Tyne, UNITED KINGDOM
firstname.lastname@example.orgDr. John Dark is Professor of Cardiothoracic Surgery and Consultant Cardiothoracic Surgeon at Newcastle University and Freeman Hospital. He was an original member of the United Kingdom Xenotransplantation Interim Regulatory Authority (UKXIRA), serves on the Ethics Committee and Council of the British Transplant Society.NURSING, HEALTH SCIENCES & ALLIED HEALTH RESEARCH GRANT AWARDS:TRANSPLANT REGISTRY EARLY CAREER AWARDS:
University of Utah
Salt Lake City, Utah, USA
email@example.comJosef Stehlik, MD, MPH is an Associate Professor of Medicine at the University of Utah School of Medicine. Dr. Stehlik received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCP*Hahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic. Dr. Stehlik has been on faculty at the University of Utah since 2004 and serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center. He has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support.